Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-25-003512

Options or other derivatives

  • PRESIDENT AND CEO acquired 490,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kintz Samuel · PRESIDENT AND CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-06 Grant or award : show line 1 in the form Stock Option (right to buy) +490,000 490,000 D
Loading xslF345X05/form4-02102025_100227.xml…